We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cello Health Plc | LSE:CLL | London | Ordinary Share | GB00B0310763 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 161.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCLL
RNS Number : 9990K
Cello Group plc
16 April 2018
FOR IMMEDIATE RELEASE 16 April 2018
Cello Group plc
("Cello" or the "Group")
Annual Report and Notice of AGM
Cello Group plc (AIM: CLL), the healthcare-focused advisory group, announces that it is today posting to shareholders its annual report and accounts for the year ended 31 December 2017 together with the notice of Annual General Meeting ("AGM").
Copies of the annual report and accounts, and the notice of AGM, are available to view on the Company's website, www.cellogroup.com.
The AGM will be held at the offices of Buchanan, 107 Cheapside, London, EC2V 6DN, at 12.30pm on Wednesday 9 May 2018.
Enquiries:
Cello Group plc 020 7812 8460 Mark Scott, Chief Executive Mark Bentley, Group Finance Director Cenkos Securities plc Bobbie Hilliam 020 7397 8927 Buchanan Mark Court 020 7466 5000 Jamie Hooper Sophie Wills
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGIGDSGDBBGIL
(END) Dow Jones Newswires
April 16, 2018 04:30 ET (08:30 GMT)
1 Year Cello Health Chart |
1 Month Cello Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
